drugset / Trial / NCT03344861

Safety of PDT-Photofrin® Prior to Lung Surgery

NCT03344861

Phase 1 Completed 10 enrolled Concordia Laboratories Inc.
NaSingle-groupOpen-labelOther

Summary

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

Timeline

Start
2017-08-14
Primary completion
2019-03-22
Completion
2019-03-22

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule 2 mg/kg Intravenous

Indications